Methimazole-induced cholestatic hepatitis: two cases report and literature review

Methimazole is commonly prescribed for patients who are thyrotoxic. Cholestatic hepatitis is a rare but serious adverse event which may be associated with interventional therapy. In this case report, we present two Chinese women with cholestatic jaundice due to methimazole treatment. Both patients h...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Hai, Jin, Lie, Wang, Li-Ren, Braddock, Martin, Cai, Wen-Wei, Zheng, Ming-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826268/
https://www.ncbi.nlm.nih.gov/pubmed/26498145
http://dx.doi.org/10.18632/oncotarget.6144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826268/
https://www.ncbi.nlm.nih.gov/pubmed/26498145
http://dx.doi.org/10.18632/oncotarget.6144

Ejemplares similares